Laura Chico

Laura Chico Analyst Performance

Managing Director, Equity Research at Wedbush

Laura Chico is a stock analyst at Wedbush focused in the healthcare sector, covering 46 publicly traded companies. Over the past year, Laura Chico has issued 106 stock ratings, including strong buy, buy, hold, and sell recommendations. While full access to Laura Chico's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Laura Chico's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
257 Last 8 Years
Buy Recommendations
71.26% 181 Buy Ratings
Companies Covered
46 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.8%2 ratings
Buy70.5%179 ratings
Hold24.4%62 ratings
Sell4.3%11 ratings

Out of 254 total stock ratings issued by Laura Chico at Wedbush, the majority (70.5%) have been Buy recommendations, followed by 24.4% Hold, 4.3% Sell, and 0.8% Strong Buy.

Exchange Coverage

ExchangePercentageCount
NASDAQ
91.3% of companies on NASDAQ
42 companies
NYSE
6.5% of companies on NYSE
3 companies
OTCMKTS
2.2% of companies on OTCMKTS
1 company

Laura Chico, an analyst at Wedbush, currently covers 46 companies listed on NASDAQ, NYSE and OTCMKTS, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Healthcare
42 companies
91.3%
Miscellaneous
2 companies
4.3%
Consumer Discretionary
1 company
2.2%
Technology
1 company
2.2%

Laura Chico of Wedbush specializes in stock coverage within the Healthcare sector, with additional focus on and Consumer Discretionary companies.

Coverage Industries

IndustryPercentage
BIOTECHNOLOGY
35 companies
76.1%
PHARMACEUTICALS
7 companies
15.2%
Miscellaneous
2 companies
4.3%
HOUSEHOLD DURABLES
1 company
2.2%
SOFTWARE
1 company
2.2%

About Laura Chico

Laura brings more than a decade of experience in the biotechnology and drug discovery industry, as well as nine years in Equity Research. During her career, Laura has served as Vice President Equity Research at Raymond James, and as a biotech analyst in the Robert W. Baird Equity Research Healthcare group. Before entering equity research, Laura held scientific roles in both industry and academic settings with focus in central nervous system (“CNS”) diseases such as Alzheimer’s disease. Laura received her B.S. in Bacteriology from the University of Wisconsin-Madison, her M.S. in Computational Biology & Bioinformatics, and her Ph.D. in Molecular Pharmacology, from Northwestern University. She continues to serve as an adjunct assistant professor at Northwestern University’s Feinberg School of Medicine.
Follow on LinkedIn

Laura Chico's Ratings History at Wedbush

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
0 Results
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Larimar Therapeutics, Inc. stock logo
LRMR
Larimar Therapeutics
11/16/2026Lower Price Target$3.00$9.00Outperform
Mentari Therapeutics stock logo
MTRI
Mentari Therapeutics
11/13/2026Initiated Coverage$18.35$33.00Outperform
PepGen, Inc. stock logo
PEPG
PepGen
11/11/2026Boost Price Target$4.61$10.00Outperform
Gossamer Bio, Inc. stock logo
GOSS
Gossamer Bio
11/11/2026Lower Price Target$10.08$32.00Neutral
Larimar Therapeutics, Inc. stock logo
LRMR
Larimar Therapeutics
11/10/2026Reiterated Rating$2.53Outperform
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
11/10/2026Boost Price Target$331.12$189.00Underperform
Maze Therapeutics, Inc. stock logo
MAZE
Maze Therapeutics
11/10/2026Boost Price Target$34.98$49.00Outperform
Vera Therapeutics, Inc. stock logo
VERA
Vera Therapeutics
11/6/2026Lower Price Target$30.14$29.00Neutral
Climb Bio, Inc. stock logo
CLYM
Climb Bio
11/5/2026Boost Price Target$8.52$27.00Outperform
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
11/5/2026Boost Price Target$29.06$42.00Outperform
BioCryst Pharmaceuticals, Inc. stock logo
BCRX
BioCryst Pharmaceuticals
11/5/2026Lower Price Target$8.24$17.00Outperform
Edgewise Therapeutics, Inc. stock logo
EWTX
Edgewise Therapeutics
11/5/2026Lower Price Target$37.53$51.00Outperform
Denali Therapeutics Inc. stock logo
DNLI
Denali Therapeutics
11/4/2026Boost Price Target$19.45$24.00Outperform
Ultragenyx Pharmaceutical Inc. stock logo
RARE
Ultragenyx Pharmaceutical
11/4/2026Lower Price Target$16.68$22.00Neutral
Biogen Inc. stock logo
BIIB
Biogen
10/29/2026Boost Price Target$244.05$225.00Neutral
Cyclerion Therapeutics, Inc. stock logo
KRSA
Cyclerion Therapeutics
10/5/2026Initiated Coverage$30.49$44.00Outperform
Jade Biosciences, Inc. stock logo
JBIO
Jade Biosciences
10/1/2026Reiterated Rating$14.05$47.00Outperform
Maze Therapeutics, Inc. stock logo
MAZE
Maze Therapeutics
9/23/2026Reiterated Rating$28.38$48.00Outperform
Travere Therapeutics, Inc. stock logo
TVTX
Travere Therapeutics
9/22/2026Reiterated Rating$62.86$76.00Outperform
Xenon Pharmaceuticals Inc. stock logo
XENE
Xenon Pharmaceuticals
9/18/2026Lower Price Target$44.08$55.00Outperform
Sionna Therapeutics, Inc. stock logo
SION
Sionna Therapeutics
9/15/2026Boost Price Target$7.36$6.00Neutral
Pharvaris N.V. stock logo
PHVS
Pharvaris
9/9/2026Boost Price Target$37.68$50.00Outperform
Pharvaris N.V. stock logo
PHVS
Pharvaris
9/8/2026Reiterated Rating$35.25$42.00Outperform
Ultragenyx Pharmaceutical Inc. stock logo
RARE
Ultragenyx Pharmaceutical
9/3/2026Lower Price Target$26.53$23.00Neutral
Climb Bio, Inc. stock logo
CLYM
Climb Bio
8/19/2026Reiterated Rating$17.39$20.00Outperform
Ardelyx, Inc. stock logo
ARDX
Ardelyx
8/18/2026Reiterated Rating$4.06$9.00Outperform
Vera Therapeutics, Inc. stock logo
VERA
Vera Therapeutics
8/17/2026Reiterated Rating$31.63$34.00Neutral
Alto Neuroscience, Inc. stock logo
ANRO
Alto Neuroscience
8/13/2026Boost Price Target$29.12$26.00Neutral
Vera Therapeutics, Inc. stock logo
VERA
Vera Therapeutics
8/11/2026Lower Price Target$30.76$34.00Neutral
Jade Biosciences, Inc. stock logo
JBIO
Jade Biosciences
8/10/2026Boost Price Target$21.95$47.00Outperform
Sionna Therapeutics, Inc. stock logo
SION
Sionna Therapeutics
8/10/2026Downgrade$4.08$5.00Neutral
Travere Therapeutics, Inc. stock logo
TVTX
Travere Therapeutics
8/6/2026Boost Price Target$64.22$75.00Outperform
BioCryst Pharmaceuticals, Inc. stock logo
BCRX
BioCryst Pharmaceuticals
8/6/2026Lower Price Target$9.43$20.00Outperform
Larimar Therapeutics, Inc. stock logo
LRMR
Larimar Therapeutics
8/5/2026Lower Price Target$4.11$11.00Outperform
Dianthus Therapeutics, Inc. stock logo
DNTH
Dianthus Therapeutics
8/5/2026Boost Price Target$110.92$122.00Outperform
Stoke Therapeutics, Inc. stock logo
STOK
Stoke Therapeutics
8/4/2026Boost Price Target$29.56$40.00Outperform
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
8/3/2026Boost Price Target$166.80$194.00Outperform
Biogen Inc. stock logo
BIIB
Biogen
7/30/2026Boost Price Target$206.17$215.00Neutral
Climb Bio, Inc. stock logo
CLYM
Climb Bio
7/27/2026Boost Price Target$12.84$20.00Outperform
Denali Therapeutics Inc. stock logo
DNLI
Denali Therapeutics
7/13/2026Reiterated Rating$25.64$26.00Outperform
I'm handing you this stock today (Ad)

Elon doesn't own the chip inside his Teslas or Starlink dishes. He licenses it from one little known public company. Now he's planning 1,000,000 AI satellites in orbit, and every one could pay this company a royalty. Analyst Dylan says the window to get in closes around December 8th, before new money floods into the buildout.tc pixel

Download this free stock pick before December 8th arrives
Biogen Inc. stock logo
BIIB
Biogen
7/13/2026Reiterated Rating$202.06$201.00Neutral
Vera Therapeutics, Inc. stock logo
VERA
Vera Therapeutics
7/8/2026Boost Price Target$42.96$43.00Neutral
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
6/30/2026Boost Price Target$18.79$43.00Outperform
Travere Therapeutics, Inc. stock logo
TVTX
Travere Therapeutics
6/22/2026Boost Price Target$55.15$61.00Outperform
Climb Bio, Inc. stock logo
CLYM
Climb Bio
6/12/2026Reiterated Rating$11.12$17.00Outperform
Travere Therapeutics, Inc. stock logo
TVTX
Travere Therapeutics
6/3/2026Reiterated Rating$42.94$55.00Outperform
Jade Biosciences, Inc. stock logo
JBIO
Jade Biosciences
6/2/2026Boost Price Target$18.59$45.00Outperform
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
6/2/2026Lower Price Target$303.77$162.00Underperform
Edgewise Therapeutics, Inc. stock logo
EWTX
Edgewise Therapeutics
6/1/2026Boost Price Target$40.26$52.00Outperform
Larimar Therapeutics, Inc. stock logo
LRMR
Larimar Therapeutics
5/18/2026Lower Price Target$3.58$12.00Outperform
Alto Neuroscience, Inc. stock logo
ANRO
Alto Neuroscience
5/14/2026Boost Price Target$22.94$24.00Neutral
PepGen, Inc. stock logo
PEPG
PepGen
5/13/2026Lower Price Target$1.61$4.00Outperform
Solid Biosciences Inc. stock logo
SLDB
Solid Biosciences
5/13/2026Lower Price Target$7.78$16.00Outperform
Jade Biosciences, Inc. stock logo
JBIO
Jade Biosciences
5/11/2026Boost Price Target$25.81$34.00Outperform
Climb Bio, Inc. stock logo
CLYM
Climb Bio
5/8/2026Boost Price Target$11.94$17.00Outperform
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
5/8/2026Boost Price Target$334.73$166.00Underperform
Denali Therapeutics Inc. stock logo
DNLI
Denali Therapeutics
5/8/2026Lower Price Target$19.89$23.00Outperform
BioCryst Pharmaceuticals, Inc. stock logo
BCRX
BioCryst Pharmaceuticals
5/7/2026Lower Price Target$8.66$21.00Outperform
Dianthus Therapeutics, Inc. stock logo
DNTH
Dianthus Therapeutics
5/6/2026Boost Price Target$90.24$105.00Outperform
Ultragenyx Pharmaceutical Inc. stock logo
RARE
Ultragenyx Pharmaceutical
5/6/2026Lower Price Target$25.01$26.00Neutral
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
5/6/2026Boost Price Target$135.06$176.00Outperform
Travere Therapeutics, Inc. stock logo
TVTX
Travere Therapeutics
5/5/2026Boost Price Target$44.91$55.00Outperform
Sionna Therapeutics, Inc. stock logo
SION
Sionna Therapeutics
5/5/2026Initiated Coverage$40.45$53.00Outperform
Sionna Therapeutics, Inc. stock logo
SION
Sionna Therapeutics
5/4/2026Upgrade$40.97Strong-Buy
Biogen Inc. stock logo
BIIB
Biogen
4/30/2026Boost Price Target$194.38$196.00Neutral
Ovid Therapeutics stock logo
OVID
Ovid Therapeutics
4/15/2026Reiterated Rating$2.96$7.00Outperform
Travere Therapeutics, Inc. stock logo
TVTX
Travere Therapeutics
4/14/2026Boost Price Target$41.18$44.00Outperform
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
4/8/2026Lower Price Target$13.96$31.00Outperform
Pharvaris N.V. stock logo
PHVS
Pharvaris
4/7/2026Boost Price Target$28.37$42.00Outperform
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
4/7/2026Boost Price Target$132.48$166.00Outperform
Alto Neuroscience, Inc. stock logo
ANRO
Alto Neuroscience
4/2/2026Lower Price Target$20.41$21.00Neutral
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
3/31/2026Lower Price Target$18.82$37.00Outperform
PepGen, Inc. stock logo
PEPG
PepGen
3/31/2026Lower Price Target$1.44$5.00Outperform
Larimar Therapeutics, Inc. stock logo
LRMR
Larimar Therapeutics
3/20/2026Boost Price Target$4.47$13.00Outperform
Ovid Therapeutics stock logo
OVID
Ovid Therapeutics
3/20/2026Boost Price Target$2.30$7.00Outperform
Edgewise Therapeutics, Inc. stock logo
EWTX
Edgewise Therapeutics
3/17/2026Reiterated Rating$29.78$32.00Outperform
Stoke Therapeutics, Inc. stock logo
STOK
Stoke Therapeutics
3/17/2026Boost Price Target$33.96$38.00Outperform
Alto Neuroscience, Inc. stock logo
ANRO
Alto Neuroscience
3/17/2026Boost Price Target$24.27$22.00Neutral
Xenon Pharmaceuticals Inc. stock logo
XENE
Xenon Pharmaceuticals
3/16/2026Lower Price Target$55.23$63.00Outperform
Maze Therapeutics, Inc. stock logo
MAZE
Maze Therapeutics
3/16/2026Boost Price Target$50.21$58.00Outperform
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
3/11/2026Reiterated Rating$29.19$44.00Outperform
Solid Biosciences Inc. stock logo
SLDB
Solid Biosciences
3/11/2026Reiterated Rating$8.18$14.00Outperform
Xenon Pharmaceuticals Inc. stock logo
XENE
Xenon Pharmaceuticals
3/10/2026Boost Price Target$62.76$64.00Outperform
Dianthus Therapeutics, Inc. stock logo
DNTH
Dianthus Therapeutics
3/10/2026Boost Price Target$79.23$80.00Outperform
Jade Biosciences, Inc. stock logo
JBIO
Jade Biosciences
3/9/2026Reiterated Rating$14.05$24.00Outperform
Climb Bio, Inc. stock logo
CLYM
Climb Bio
3/5/2026Initiated Coverage$7.28$12.00Outperform
Larimar Therapeutics, Inc. stock logo
LRMR
Larimar Therapeutics
3/3/2026Boost Price Target$5.36$12.00Outperform
Larimar Therapeutics, Inc. stock logo
LRMR
Larimar Therapeutics
2/25/2026Reiterated Rating$3.69$11.00Outperform
Apellis Pharmaceuticals, Inc. stock logo
APLS
Apellis Pharmaceuticals
2/25/2026Lower Price Target$22.13$18.00Neutral
Gossamer Bio, Inc. stock logo
GOSS
Gossamer Bio
2/24/2026Reiterated Rating$33.60$80.00Neutral
Earn $4,500 a month? Your income may count for more (Ad)

Earn $4,500 or more a month? Pennie lets you explore personal loan options that consider your income, not just your credit score. Options include personal loans up to $250,000 and APRs starting at 5.99%. Checking your rate is free, and the soft credit check won't affect your score. Pennie is a loan marketplace, not a lender. Offers come from third-party partners and are not guaranteed.tc pixel

Check your personal loan rate with Pennie in about two minutes with no fee
Ardelyx, Inc. stock logo
ARDX
Ardelyx
2/23/2026Reiterated Rating$5.73$19.00Outperform
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
2/20/2026Boost Price Target$331.61$130.00Underperform
Ultragenyx Pharmaceutical Inc. stock logo
RARE
Ultragenyx Pharmaceutical
2/17/2026Reiterated Rating$20.66$25.00Neutral
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
2/12/2026Boost Price Target$126.00$151.00Outperform
Dianthus Therapeutics, Inc. stock logo
DNTH
Dianthus Therapeutics
2/11/2026Boost Price Target$49.44$55.00Outperform
Biogen Inc. stock logo
BIIB
Biogen
2/9/2026Boost Price Target$201.18$187.00Neutral
Ardelyx, Inc. stock logo
ARDX
Ardelyx
1/21/2026Boost Price Target$7.76$19.00Outperform
Stoke Therapeutics, Inc. stock logo
STOK
Stoke Therapeutics
1/12/2026Boost Price Target$32.85$36.00Outperform
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
1/12/2026Boost Price Target$288.45$95.00Underperform
Dianthus Therapeutics, Inc. stock logo
DNTH
Dianthus Therapeutics
12/22/2025Reiterated Rating$42.44$46.00Outperform
Vera Therapeutics, Inc. stock logo
VERA
Vera Therapeutics
12/11/2025Boost Price Target$44.34$33.00Neutral
Denali Therapeutics Inc. stock logo
DNLI
Denali Therapeutics
12/11/2025Lower Price Target$17.49$30.00Outperform
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
12/10/2025Boost Price Target$31.80$47.00Outperform
Denali Therapeutics Inc. stock logo
DNLI
Denali Therapeutics
12/5/2025Boost Price Target$20.11$31.00Outperform
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
12/5/2025Reiterated Rating$189.97$83.00Underperform
Ardelyx, Inc. stock logo
ARDX
Ardelyx
11/25/2025Downgrade$5.50Hold
Pharvaris N.V. stock logo
PHVS
Pharvaris
11/13/2025Boost Price Target$26.13$30.00Outperform
Maze Therapeutics, Inc. stock logo
MAZE
Maze Therapeutics
11/7/2025Boost Price Target$29.21$36.00Outperform
Edgewise Therapeutics, Inc. stock logo
EWTX
Edgewise Therapeutics
11/7/2025Lower Price Target$17.58$32.00Outperform
Dianthus Therapeutics, Inc. stock logo
DNTH
Dianthus Therapeutics
11/6/2025Boost Price Target$33.73$46.00Outperform
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
11/6/2025Boost Price Target$164.64$77.00Underperform
Stoke Therapeutics, Inc. stock logo
STOK
Stoke Therapeutics
11/5/2025Boost Price Target$21.20$32.00Outperform
Astria Therapeutics, Inc. stock logo
ATXS
Astria Therapeutics
10/15/2025Set Price Target$11.61$13.00Neutral
Astria Therapeutics, Inc. stock logo
ATXS
Astria Therapeutics
10/15/2025Downgrade$11.92$13.00Neutral
Larimar Therapeutics, Inc. stock logo
LRMR
Larimar Therapeutics
9/30/2025Lower Price Target$3.38$11.00Outperform
PepGen, Inc. stock logo
PEPG
PepGen
9/25/2025Boost Price Target$5.97$9.00Outperform
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
9/22/2025Reiterated Rating$146.62Outperform
Dianthus Therapeutics, Inc. stock logo
DNTH
Dianthus Therapeutics
9/12/2025Boost Price Target$37.86$44.00Outperform
Tourmaline Bio, Inc. stock logo
TRML
Tourmaline Bio
9/9/2025Downgrade$30.18$48.00Neutral
Dianthus Therapeutics, Inc. stock logo
DNTH
Dianthus Therapeutics
8/21/2025Boost Price Target$23.72$42.00Outperform
Jade Biosciences, Inc. stock logo
JBIO
Jade Biosciences
8/14/2025Boost Price Target$7.03$18.00Outperform
Solid Biosciences Inc. stock logo
SLDB
Solid Biosciences
8/13/2025Lower Price Target$6.15$14.00Outperform
Stoke Therapeutics, Inc. stock logo
STOK
Stoke Therapeutics
8/13/2025Boost Price Target$15.66$22.00Outperform
Xenon Pharmaceuticals Inc. stock logo
XENE
Xenon Pharmaceuticals
8/12/2025Boost Price Target$36.10$43.00Outperform
Travere Therapeutics, Inc. stock logo
TVTX
Travere Therapeutics
8/7/2025Boost Price Target$17.24$32.00Outperform
Gossamer Bio, Inc. stock logo
GOSS
Gossamer Bio
8/6/2025Boost Price Target$157.20$400.00Outperform
Ardelyx, Inc. stock logo
ARDX
Ardelyx
8/5/2025Reiterated Rating$5.08$14.00Outperform
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
7/31/2025Boost Price Target$136.76$141.00Outperform
Ultragenyx Pharmaceutical Inc. stock logo
RARE
Ultragenyx Pharmaceutical
7/14/2025Lower Price Target$29.51$34.00Neutral
Maze Therapeutics, Inc. stock logo
MAZE
Maze Therapeutics
7/8/2025Initiated Coverage$12.12$17.00Outperform
BioCryst Pharmaceuticals, Inc. stock logo
BCRX
BioCryst Pharmaceuticals
6/30/2025Boost Price Target$9.36$18.00Outperform
Larimar Therapeutics, Inc. stock logo
LRMR
Larimar Therapeutics
6/24/2025Lower Price Target$2.76$15.00Outperform
Lennar Corporation stock logo
LEN
Lennar
6/18/2025Reiterated Rating$105.15$130.00Neutral
Biogen Inc. stock logo
BIIB
Biogen
6/12/2025Reiterated Rating$132.63$121.00Neutral
Pharvaris N.V. stock logo
PHVS
Pharvaris
6/5/2025Reiterated Rating$16.88$27.00Outperform
Travere Therapeutics, Inc. stock logo
TVTX
Travere Therapeutics
5/16/2025Reiterated Rating$17.51$30.00Outperform
Gossamer Bio, Inc. stock logo
GOSS
Gossamer Bio
5/16/2025Reiterated Rating$86.00$320.00Outperform
Solid Biosciences Inc. stock logo
SLDB
Solid Biosciences
5/16/2025Lower Price Target$2.87$17.00Outperform
Alto Neuroscience, Inc. stock logo
ANRO
Alto Neuroscience
5/15/2025Reiterated Rating$2.26$4.00Neutral
Denali Therapeutics Inc. stock logo
DNLI
Denali Therapeutics
5/7/2025Lower Price Target$14.02$30.00Outperform
Your $7 scanner is waiting (Ad)

The Instant Scanner is $7 in Bill Poulos's Black Friday sale. Every night it delivers a list showing which stock, what price, and when to exit. The list reads the same whether you've traded for twenty years or twenty days, and it doesn't depend on account size. If it's not for you, refund the $7 and still keep the scanner for the full year. One payment, no re-bills.tc pixel

Get the Instant Scanner for $7 in the Black Friday sale today.
Vera Therapeutics, Inc. stock logo
VERA
Vera Therapeutics
5/7/2025Lower Price Target$22.33$26.00Neutral
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
5/5/2025Boost Price Target$39.96$28.00Underperform
Travere Therapeutics, Inc. stock logo
TVTX
Travere Therapeutics
5/2/2025Reiterated Rating$20.56$30.00Outperform
Edgewise Therapeutics, Inc. stock logo
EWTX
Edgewise Therapeutics
4/21/2025Reiterated Rating$13.67$43.00Outperform
Tourmaline Bio, Inc. stock logo
TRML
Tourmaline Bio
3/14/2025Boost Price Target$18.31$43.00Outperform
Gossamer Bio, Inc. stock logo
GOSS
Gossamer Bio
3/14/2025Reiterated Rating$107.60$320.00Outperform
Ovid Therapeutics stock logo
OVID
Ovid Therapeutics
3/12/2025Reiterated Rating$0.49$3.00Outperform
Astria Therapeutics, Inc. stock logo
ATXS
Astria Therapeutics
3/12/2025Reiterated Rating$6.47$28.00Outperform
Dianthus Therapeutics, Inc. stock logo
DNTH
Dianthus Therapeutics
3/12/2025Reiterated Rating$22.69$36.00Outperform
Tourmaline Bio, Inc. stock logo
TRML
Tourmaline Bio
3/6/2025Initiated Coverage$12.90$42.00Outperform
Apellis Pharmaceuticals, Inc. stock logo
APLS
Apellis Pharmaceuticals
3/3/2025Lower Price Target$25.15$29.00Neutral
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
2/28/2025Downgrade$33.55Strong Sell
BioCryst Pharmaceuticals, Inc. stock logo
BCRX
BioCryst Pharmaceuticals
2/25/2025Initiated Coverage$8.29$15.00Outperform
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
2/7/2025Lower Price Target$121.12$147.00Outperform
Ultragenyx Pharmaceutical Inc. stock logo
RARE
Ultragenyx Pharmaceutical
1/13/2025Reiterated Rating$41.84$48.00Neutral
Solid Biosciences Inc. stock logo
SLDB
Solid Biosciences
12/12/2024Upgrade$4.91Strong-Buy